Suppr超能文献

阿片类物质使用障碍个体中Connor-Davidson心理韧性量表(CD-RISC)的因子结构和心理测量学特性

Factor structure and psychometric properties of the Connor-Davidson resilience scale (CD-RISC) in individuals with opioid use disorder.

作者信息

Martinez Suky, Jones Jermaine D, Brandt Laura, Hien Denise, Campbell Aimee N C, Batchelder Sarai, Comer Sandra D

机构信息

Division on Substance Use Disorders, New York State Psychiatric Institute, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.

Division on Substance Use Disorders, New York State Psychiatric Institute, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.

出版信息

Drug Alcohol Depend. 2021 Apr 1;221:108632. doi: 10.1016/j.drugalcdep.2021.108632. Epub 2021 Feb 16.

Abstract

AIMS

Resilience is defined as the capacity for an individual to maintain normal functioning and resist the development of psychiatric disorders in response to stress and trauma. Although previous investigators have acknowledged the important role of resilience in those with substance use disorders, this is the first study to investigate the reliability, validity, and factor structure of the Connor-Davidson Resilience Scale (CD-RISC-25) in a sample of individuals with opioid use disorder (OUD). Additionally, we explored the relationship between trait resilience and the severity of drug-related problems.

METHODS

Four hundred and three participants (22 % female) with OUD completed the CD-RISC-25, Beck Depression Inventory (BDI-II), and the self-report Addiction Severity Index (ASI). Confirmatory factor analysis (CFA) tested the originally proposed 5-factor solution of the CD-RISC-25.

RESULTS

CFA results indicated that a 5-factor model of the CD-RISC-25 performed somewhat better than the 1-factor solution. Pearson correlation revealed a negative association between CD-RISC-25 (M = 75.82, SD = 15.78) and ASI drug-use composite score (M = .25, SD=-0.16), r=-0.148, p<.01, and between CD-RISC-25 and BDI-II (M = 11.33, SD = 10.58), r=-.237, p<.001.

CONCLUSIONS

Albeit providing only limited support for the original 5-factor structure, our results indicate that the scale may be useful for screening individuals with OUD who have a vulnerability to stress. Consistent with prior studies, higher resilience was associated with lower depression symptoms and addiction severity, further demonstrating the CD-RISC-25 ability to predict psychiatric stability. To inform the development of more targeted interventions, future studies should examine resilience longitudinally, in addition to exploring more comprehensive approaches to measuring resilience.

摘要

目的

心理韧性被定义为个体在面对压力和创伤时维持正常功能并抵御精神障碍发展的能力。尽管先前的研究者已经认识到心理韧性在物质使用障碍患者中的重要作用,但这是第一项在阿片类物质使用障碍(OUD)个体样本中调查Connor-Davidson心理韧性量表(CD-RISC-25)的信度、效度和因子结构的研究。此外,我们还探讨了特质心理韧性与药物相关问题严重程度之间的关系。

方法

403名患有OUD的参与者(22%为女性)完成了CD-RISC-25、贝克抑郁量表(BDI-II)和自我报告成瘾严重程度指数(ASI)。验证性因子分析(CFA)检验了CD-RISC-25最初提出的五因子模型。

结果

CFA结果表明,CD-RISC-25的五因子模型比单因子模型表现稍好。Pearson相关性分析显示,CD-RISC-25(M = 75.82,SD = 15.78)与ASI药物使用综合评分(M = 0.25,SD = -0.16)之间呈负相关,r = -0.148,p <.01;CD-RISC-25与BDI-II(M = 11.33,SD = 10.58)之间也呈负相关,r = -0.237,p <.001。

结论

尽管我们的结果仅为CD-RISC-25最初的五因子结构提供了有限支持,但表明该量表可能有助于筛查易受压力影响的OUD个体。与先前的研究一致,较高的心理韧性与较低的抑郁症状和成瘾严重程度相关,进一步证明了CD-RISC-25预测精神稳定性的能力。为了为更有针对性的干预措施的开发提供信息,未来的研究除了探索更全面的心理韧性测量方法外,还应纵向研究心理韧性。

相似文献

1
Factor structure and psychometric properties of the Connor-Davidson resilience scale (CD-RISC) in individuals with opioid use disorder.
Drug Alcohol Depend. 2021 Apr 1;221:108632. doi: 10.1016/j.drugalcdep.2021.108632. Epub 2021 Feb 16.
2
Psychometric properties of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10) in Chinese undergraduates and depressive patients.
J Affect Disord. 2020 Jan 15;261:211-220. doi: 10.1016/j.jad.2019.10.018. Epub 2019 Oct 12.
4
The Korean version of the Connor-Davidson Resilience Scale: an extended validation.
Stress Health. 2012 Oct;28(4):319-26. doi: 10.1002/smi.1436. Epub 2012 Jan 16.
5
Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in Sweden.
Health Qual Life Outcomes. 2020 May 12;18(1):132. doi: 10.1186/s12955-020-01383-3.
6
Psychometric properties of two abbreviated Connor-Davidson Resilience scales in Chinese infertile couples.
Qual Life Res. 2021 Aug;30(8):2405-2414. doi: 10.1007/s11136-021-02820-6. Epub 2021 Apr 3.
7
Factor structure and psychometric properties of the Connor-Davidson Resilience Scale among Chinese adolescents.
Compr Psychiatry. 2011 Mar-Apr;52(2):218-24. doi: 10.1016/j.comppsych.2010.05.010.

引用本文的文献

1
The INFINITE Study: Pilot Research Exploring Plant-Based Nutrition in Treatment for Substance Use Disorders.
Am J Lifestyle Med. 2022 Aug 16;19(4):572-584. doi: 10.1177/15598276221120227. eCollection 2025 May-Jun.
2
Development and validation of the multi-dimensional health resilience scale for community-dwelling adults.
Front Public Health. 2025 Feb 12;13:1452738. doi: 10.3389/fpubh.2025.1452738. eCollection 2025.
4
Connor-Davidson Resilience Scale: a systematic review psychometrics properties using the COSMIN.
Ann Med Surg (Lond). 2024 Mar 27;86(5):2976-2991. doi: 10.1097/MS9.0000000000001968. eCollection 2024 May.
6
Validating the Arabic version of the Connor-Davidson resilience scale among university students.
PLoS One. 2023 Oct 24;18(10):e0293384. doi: 10.1371/journal.pone.0293384. eCollection 2023.
7
Resilience Phenotypes and Psychological Functioning among Individuals with Opioid Use Disorder.
Subst Use Misuse. 2024;59(1):41-49. doi: 10.1080/10826084.2023.2259450. Epub 2023 Dec 1.
9
A prospective assessment of resilience in trauma patients using the Connor-Davidson Resilience Scale.
Surgery. 2023 Nov;174(5):1249-1254. doi: 10.1016/j.surg.2023.07.012. Epub 2023 Aug 19.
10
Psychometric evaluation of the Connor-Davidson Resilience Scale among Iranian population.
BMC Psychiatry. 2023 Feb 7;23(1):92. doi: 10.1186/s12888-023-04580-8.

本文引用的文献

1
The Importance of Studying Sex and Gender Differences in Opioid Misuse.
JAMA Netw Open. 2020 Dec 1;3(12):e2030676. doi: 10.1001/jamanetworkopen.2020.30676.
2
Intervention in an opioid overdose event increases interest in treatment among individuals with opioid use disorder.
Subst Abus. 2021;42(4):407-411. doi: 10.1080/08897077.2020.1809607. Epub 2020 Aug 19.
3
The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States.
Addiction. 2020 May;115(5):946-958. doi: 10.1111/add.14878. Epub 2020 Jan 7.
4
Connor-Davidson Resilience Scale: validation study in a Portuguese sample.
BMJ Open. 2019 Jun 27;9(6):e026836. doi: 10.1136/bmjopen-2018-026836.
5
What contributes to resilience in cancer patients? A principal component analysis of the Connor-Davidson Resilience Scale.
Asia Pac J Clin Oncol. 2019 Oct;15(5):e115-e119. doi: 10.1111/ajco.13128. Epub 2019 Feb 11.
6
The neurobiology of addiction.
Ann N Y Acad Sci. 2019 Sep;1451(1):5-28. doi: 10.1111/nyas.13989. Epub 2019 Jan 15.
7
Cognitive impairment in substance use disorders.
CNS Spectr. 2019 Feb;24(1):102-113. doi: 10.1017/S1092852918001426. Epub 2018 Dec 28.
8
Prevention and Treatment of Opioid Misuse and Addiction: A Review.
JAMA Psychiatry. 2019 Feb 1;76(2):208-216. doi: 10.1001/jamapsychiatry.2018.3126.
10
Trends in Black and White Opioid Mortality in the United States, 1979-2015.
Epidemiology. 2018 Sep;29(5):707-715. doi: 10.1097/EDE.0000000000000858.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验